General Information
Version
1.3
Revision date
2011-10-01
Product name
EVISTA TABLETS
Substance name
000004269883
Product Synonyms
Raloxifene Hydrochloride Tablets
Chemical name
Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride Lilly Serial Number : 156758
CAS No.
82640-04-8
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Eli Lilly and Company
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Lilly Lab Labeling Code Health: 2 Special: Fire: 1 P, R, sC Reactivity: 0 Special: Highly Potent, Reproductive Hazard, Suspect Carcinogen Primary Hazards: Not hazardous if intact, Irritant (skin), Highly Potent, Reproductive, Suspect Carcinogen Hazard Summary (Caution) Not hazardous if intact. Effects of exposure to contents May cause skin irritation. Highly Potent. This product may cause adverse reproductive effects. May cause cancer. Emergency Overview Form tablet Colour light yellow Odour odourless
Potential health effects
Skin May irritate skin.
Medical Conditions Generally Aggravated by Exposure
None known.
Principle Routes of Exposure
Inhalation Skin contact Symptoms of Overexposure Exposure to raloxifene hydrochloride resulted in skin rash/redness. Reproductive and/or developmental effects are associated with compounds in this pharmacological class.
Additional information
Capsules or tablets are intended for human consumption under guidance of a physician. Carcinogenicity NTP No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP. IARC No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
